Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
Department of Clinical Neurophysiology, Danish Center for Sleep Medicine, Rigshospitalet, Denmark.
Mov Disord. 2023 Jan;38(1):82-91. doi: 10.1002/mds.29249. Epub 2022 Oct 18.
Isolated rapid-eye-movement sleep behavior disorder (iRBD) is in most cases a prodrome of neurodegenerative synucleinopathies, affecting 1% to 2% of middle-aged and older adults; however, accurate ambulatory diagnostic methods are not available. Questionnaires lack specificity in nonclinical populations. Wrist actigraphy can detect characteristic features in individuals with RBD; however, high-frequency actigraphy has been rarely used.
The aim was to develop a machine learning classifier using high-frequency (1-second resolution) actigraphy and a short patient survey for detecting iRBD with high accuracy and precision.
The method involved analysis of home actigraphy data (for seven nights and more) and a nine-item questionnaire (RBD Innsbruck inventory and three synucleinopathy prodromes of subjective hyposmia, constipation, and orthostatic dizziness) in a data set comprising 42 patients with iRBD, 21 sleep clinic patients with other sleep disorders, and 21 community controls.
The actigraphy classifier achieved 95.2% (95% confidence interval [CI]: 88.3-98.7) sensitivity and 90.9% (95% CI: 82.1-95.8) precision. The questionnaire classifier achieved 90.6% accuracy and 92.7% precision, exceeding the performance of the Innsbruck RBD Inventory and prodromal questionnaire alone. Concordant predictions between actigraphy and questionnaire reached a specificity and precision of 100% (95% CI: 95.7-100.0) with 88.1% sensitivity (95% CI: 79.2-94.1) and outperformed any combination of actigraphy and a single question on RBD or prodromal symptoms.
Actigraphy detected iRBD with high accuracy in a mixed clinical and community cohort. This cost-effective fully remote procedure can be used to diagnose iRBD in specialty outpatient settings and has potential for large-scale screening of iRBD in the general population. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
孤立性快动眼睡眠行为障碍(iRBD)在大多数情况下是神经退行性突触核蛋白病的前驱期,影响 1%至 2%的中老年人;然而,目前尚无准确的非卧床诊断方法。问卷在非临床人群中的特异性不足。腕部动作描记术可检测到 RBD 个体的特征;然而,高频动作描记术很少被使用。
旨在开发一种使用高频(1 秒分辨率)动作描记术和简短患者调查的机器学习分类器,以实现 iRBD 的高精度和高精准度检测。
该方法涉及对包含 42 例 iRBD 患者、21 例睡眠诊所其他睡眠障碍患者和 21 例社区对照患者的数据集进行家庭动作描记数据(七晚及以上)和九项问卷(因斯布鲁克 RBD 清单和三个突触核蛋白病前驱症状:嗅觉减退、便秘和直立性头晕)分析。
动作描记术分类器的敏感性为 95.2%(95%置信区间[CI]:88.3-98.7),特异性为 90.9%(95% CI:82.1-95.8)。问卷分类器的准确率为 90.6%,特异性为 92.7%,超过了因斯布鲁克 RBD 清单和前驱症状问卷的单独表现。动作描记术和问卷的一致预测达到了 100%(95%CI:95.7-100.0)的特异性和 88.1%(95%CI:79.2-94.1)的敏感性,优于任何一种组合的动作描记术和单个 RBD 或前驱症状问题。
动作描记术在混合临床和社区队列中以高准确性检测到 iRBD。这种具有成本效益的完全远程程序可用于在专科门诊环境中诊断 iRBD,并有可能在普通人群中进行大规模的 iRBD 筛查。